Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis.

PubWeight™: 3.02‹?› | Rank: Top 1%

🔗 View Article (PMID 21693740)

Published in JAMA on June 22, 2011

Authors

Daniel H Solomon1, Elena Massarotti, Rajesh Garg, Jun Liu, Claire Canning, Sebastian Schneeweiss

Author Affiliations

1: Division of Pharmacoepidemiology, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. dsolomon@partners.org

Associated clinical trials:

Assessing the Efficacy and Safety of Metformin in Treatment of Moderate Psoriasis | NCT02644954

Impact of Rheumatoid Arthritis on the Course of Type 2 Diabetes During a Longitudinal Follow-up of 5 Years (INSPIRED) | NCT02639988

Articles citing this

The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med (2012) 5.63

Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases. JAMA (2011) 3.58

An inhibitor of the protein kinases TBK1 and IKK-ɛ improves obesity-related metabolic dysfunctions in mice. Nat Med (2013) 3.15

A role for the NLRP3 inflammasome in metabolic diseases--did Warburg miss inflammation? Nat Immunol (2012) 2.59

Initiation of anti-TNF therapy and the risk of optic neuritis: from the safety assessment of biologic ThERapy (SABER) Study. Am J Ophthalmol (2012) 2.14

The inflammation highway: metabolism accelerates inflammatory traffic in obesity. Immunol Rev (2012) 2.01

[Safety of immunosuppressants]. Z Rheumatol (2012) 1.98

Psoriasis severity and the prevalence of major medical comorbidity: a population-based study. JAMA Dermatol (2013) 1.64

The Effect of Sustained Inflammation on Hepatic Mevalonate Pathway Results in Hyperglycemia. Cell (2016) 1.47

Regulation of metabolism by the innate immune system. Nat Rev Endocrinol (2015) 1.29

Use of administrative claims data for comparative effectiveness research of rheumatoid arthritis treatments. Arthritis Res Ther (2011) 1.25

Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies. J Am Heart Assoc (2013) 1.25

Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis. Rheumatology (Oxford) (2012) 1.24

Cardiovascular comorbidity in rheumatic diseases. Nat Rev Rheumatol (2015) 1.11

Gene silencing in adipose tissue macrophages regulates whole-body metabolism in obese mice. Proc Natl Acad Sci U S A (2013) 1.04

Selection bias in rheumatic disease research. Nat Rev Rheumatol (2014) 1.02

Risk of high-grade cervical dysplasia and cervical cancer in women with systemic inflammatory diseases: a population-based cohort study. Ann Rheum Dis (2014) 1.00

Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance. Arthritis Res Ther (2012) 0.99

Hydroxychloroquine improves insulin sensitivity in obese non-diabetic individuals. Arthritis Res Ther (2012) 0.97

Inverse regulation of inflammation and mitochondrial function in adipose tissue defines extreme insulin sensitivity in morbidly obese patients. Diabetes (2012) 0.96

Obesity, Diabetes, the Cardiorenal Syndrome, and Risk for Cancer. Cardiorenal Med (2012) 0.94

Central obesity, type 2 diabetes and insulin: exploring a pathway full of thorns. Arch Med Sci (2015) 0.93

Inflammation, metaflammation and immunometabolic disorders. Nature (2017) 0.93

Cardiovascular safety of biologic therapies for the treatment of RA. Nat Rev Rheumatol (2011) 0.92

Management of moderate to severe psoriasis in patients with metabolic comorbidities. Front Med (Lausanne) (2015) 0.87

Morbidity risks among older adults with pre-existing age-related diseases. Exp Gerontol (2013) 0.87

Prevalence of Undiagnosed Diabetes in Rheumatoid Arthritis: an OGTT Study. Medicine (Baltimore) (2016) 0.86

Psoriasis. Cold Spring Harb Perspect Med (2014) 0.85

Risk of rheumatoid arthritis in patients with type 2 diabetes: a nationwide population-based case-control study. PLoS One (2014) 0.84

Psoriasis and cardiometabolic traits: modest association but distinct genetic architectures. J Invest Dermatol (2015) 0.83

Targeting adipose tissue in the treatment of obesity-associated diabetes. Nat Rev Drug Discov (2016) 0.83

Inflammatory ocular adverse events with the use of oral bisphosphonates: a retrospective cohort study. CMAJ (2012) 0.83

Relationship between tumor necrosis factor-α inhibitors and cardiovascular disease in psoriasis: a review. Perm J (2014) 0.83

Positive predictive value of a case definition for diabetes mellitus using automated administrative health data in children and youth exposed to antipsychotic drugs or control medications: a Tennessee Medicaid study. BMC Med Res Methodol (2012) 0.82

A favorable effect of hydroxychloroquine on glucose and lipid metabolism beyond its anti-inflammatory role. Ther Adv Endocrinol Metab (2014) 0.82

The Obesity Epidemic and Consequences for Rheumatoid Arthritis Care. Curr Rheumatol Rep (2016) 0.81

Effect of hydroxychloroquine on insulin sensitivity and lipid parameters in rheumatoid arthritis patients without diabetes mellitus: a randomized, blinded crossover trial. Arthritis Care Res (Hoboken) (2014) 0.81

Multimorbidity in rheumatic conditions. Wien Klin Wochenschr (2016) 0.81

Risk of Incident Diabetes Mellitus Associated With the Dosage and Duration of Oral Glucocorticoid Therapy in Patients With Rheumatoid Arthritis. Arthritis Rheumatol (2016) 0.81

Hydroxychloroquine Use Is Associated With Decreased Incident Cardiovascular Events in Rheumatoid Arthritis Patients. J Am Heart Assoc (2016) 0.80

Autoimmune thyroid disease in rheumatoid arthritis: a global perspective. Arthritis (2012) 0.80

Linking inflammation to the brain-liver axis. Diabetes (2012) 0.79

The acute effects of low-dose TNF-α on glucose metabolism and β-cell function in humans. Mediators Inflamm (2014) 0.78

Comparison of the Charlson Comorbidity Index derived from self-report and medical record review in Asian patients with rheumatic diseases. Rheumatol Int (2015) 0.78

Prevalence and concomitants of arthritis in the elderly in Rio Grande do Sul, Brazil. PLoS One (2012) 0.78

[Multimorbidity in elderly rheumatic patients part 2]. Z Rheumatol (2013) 0.78

Risk of Pulmonary Embolism and Deep Venous Thrombosis in Systemic Sclerosis: A General Population-Based Study. Arthritis Care Res (Hoboken) (2016) 0.77

Predicting the 10-year risk of hip and major osteoporotic fracture in rheumatoid arthritis and in the general population: an independent validation and update of UK FRAX without bone mineral density. Ann Rheum Dis (2016) 0.77

Can treatment of chronic inflammatory diseases reduce the risk of diabetes mellitus? JAMA (2011) 0.77

Myeloid Cell-Restricted Insulin/IGF-1 Receptor Deficiency Protects against Skin Inflammation. J Immunol (2015) 0.76

Disease-modifying antirheumatic drug use and the risk of incident hyperlipidemia in patients with early rheumatoid arthritis: a retrospective cohort study. Arthritis Care Res (Hoboken) (2015) 0.76

Relationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis? Int J Mol Sci (2016) 0.76

Antidiabetogenic effects of hydroxychloroquine on insulin sensitivity and beta cell function: a randomised trial. Diabetologia (2015) 0.76

The risk of pulmonary embolism and deep venous thrombosis in systemic lupus erythematosus: A general population-based study. Semin Arthritis Rheum (2015) 0.75

Chloroquine is a zinc ionophore. PLoS One (2014) 0.75

FOCUS ON PSORIASIS: A REPORT FROM THE 73RD ANNUAL MEETING OF THE AMERICAN ACADEMY OF DERMATOLOGYPsoriasis-related topics included targeted therapies, safety of biologies, comorbidities. J Clin Aesthet Dermatol (2015) 0.75

Trends in Type of Original Psoriasis Publications by Decade, 1960 to 2010. Perm J (2016) 0.75

Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes. BMC Cardiovasc Disord (2017) 0.75

Epidemiology research in rheumatology-progress and pitfalls. Nat Rev Rheumatol (2015) 0.75

The effect of hydroxychloroquine on glucose control and insulin resistance in the prediabetes condition. Adv Biomed Res (2016) 0.75

Hit hard and early: Can the march of psoriasis be halted? Indian Dermatol Online J (2013) 0.75

Patient Preferences for Biologicals in Psoriasis: Top Priority of Safety for Cardiovascular Patients. PLoS One (2015) 0.75

An external validation study reporting poor correlation between the claims-based index for rheumatoid arthritis severity and the disease activity score. Arthritis Res Ther (2015) 0.75

Management of Hidradenitis Suppurativa in Patients with Metabolic Comorbidities. Ann Dermatol (2016) 0.75

Initiation of TNF inhibitor therapy and change in physiologic measures in psoriasis. J Eur Acad Dermatol Venereol (2013) 0.75

Metabolic reprogramming through fatty acid transport protein 1 (FATP1) regulates macrophage inflammatory potential and adipose inflammation. Mol Metab (2016) 0.75

Improvement in 5-year mortality in incident rheumatoid arthritis compared with the general population-closing the mortality gap. Ann Rheum Dis (2016) 0.75

Validity of juvenile idiopathic arthritis diagnoses using administrative health data. Rheumatol Int (2014) 0.75

Filling the gaps in SARDs research: collection and linkage of administrative health data and self-reported survey data for a general population-based cohort of individuals with and without diagnoses of systemic autoimmune rheumatic disease (SARDs) from British Columbia, Canada. BMJ Open (2017) 0.75

Adapting to obesity with adipose tissue inflammation. Nat Rev Endocrinol (2017) 0.75

Signs of innate immune activation and premature immunosenescence in psoriasis patients. Sci Rep (2017) 0.75

Association between baseline vitamin D metabolite levels and long-term cardiovascular events in patients with rheumatoid arthritis from the CIMESTRA trial: protocol for a cohort study with patient-record evaluated outcomes. BMJ Open (2017) 0.75

Articles by these authors

Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature (2007) 75.09

The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet (2006) 20.76

An oestrogen-receptor-alpha-bound human chromatin interactome. Nature (2009) 12.16

Variable selection for propensity score models. Am J Epidemiol (2006) 10.68

Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med (2005) 8.44

Urinary-cell mRNA profile and acute cellular rejection in kidney allografts. N Engl J Med (2013) 7.40

A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. J Clin Epidemiol (2005) 7.31

Whole-genome mapping of histone H3 Lys4 and 27 trimethylations reveals distinct genomic compartments in human embryonic stem cells. Cell Stem Cell (2007) 7.05

Distribution and three-dimensional structure of AIDS virus envelope spikes. Nature (2006) 6.78

Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. Am Heart J (2004) 6.57

Methylation protects miRNAs and siRNAs from a 3'-end uridylation activity in Arabidopsis. Curr Biol (2005) 5.99

Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci U S A (2009) 5.86

Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration. Science (2006) 5.52

The oyster genome reveals stress adaptation and complexity of shell formation. Nature (2012) 5.30

Predialysis nephrology care of older patients approaching end-stage renal disease. Arch Intern Med (2011) 5.11

Fusion transcripts and transcribed retrotransposed loci discovered through comprehensive transcriptome analysis using Paired-End diTags (PETs). Genome Res (2007) 4.99

Indications for propensity scores and review of their use in pharmacoepidemiology. Basic Clin Pharmacol Toxicol (2006) 4.70

Full coverage for preventive medications after myocardial infarction. N Engl J Med (2011) 4.51

Electrochemical energy storage for green grid. Chem Rev (2011) 4.48

The comparative safety of analgesics in older adults with arthritis. Arch Intern Med (2010) 4.47

Towards a transgenic model of Huntington's disease in a non-human primate. Nature (2008) 4.47

ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol Cell (2012) 4.18

Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation (2005) 4.17

A combined comorbidity score predicted mortality in elderly patients better than existing scores. J Clin Epidemiol (2011) 3.98

Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA (2009) 3.86

Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death. JAMA (2010) 3.85

Epidemiological transition of stroke in China: twenty-one-year observational study from the Sino-MONICA-Beijing Project. Stroke (2008) 3.81

The epidemiology of prescriptions abandoned at the pharmacy. Ann Intern Med (2010) 3.78

Arabidopsis HEN1: a genetic link between endogenous miRNA controlling development and siRNA controlling transgene silencing and virus resistance. Curr Biol (2003) 3.77

Altitude and all-cause mortality in incident dialysis patients. JAMA (2009) 3.62

The G(0)/G(1) switch gene 2 regulates adipose lipolysis through association with adipose triglyceride lipase. Cell Metab (2010) 3.61

Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable. Epidemiology (2006) 3.54

Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: nonsteroidal antiinflammatory drugs and short-term mortality in the elderly. Am J Epidemiol (2005) 3.33

The implications of therapeutic complexity on adherence to cardiovascular medications. Arch Intern Med (2011) 3.27

HEN1 functions pleiotropically in Arabidopsis development and acts in C function in the flower. Development (2002) 3.24

Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome. Circulation (2009) 3.09

Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis. Arthritis Rheum (2006) 3.04

Electron tomography analysis of envelope glycoprotein trimers on HIV and simian immunodeficiency virus virions. Proc Natl Acad Sci U S A (2003) 3.02

Confounding control in healthcare database research: challenges and potential approaches. Med Care (2010) 3.01

Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults. Circulation (2004) 2.98

Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles. Arthritis Rheum (2005) 2.88

Tube Formation in Nanoscale Materials. Nanoscale Res Lett (2008) 2.83

Selective prescribing led to overestimation of the benefits of lipid-lowering drugs. J Clin Epidemiol (2006) 2.81

Complex and oriented ZnO nanostructures. Nat Mater (2003) 2.75

The comparative safety of opioids for nonmalignant pain in older adults. Arch Intern Med (2010) 2.71

Comparative mortality risk of anemia management practices in incident hemodialysis patients. JAMA (2010) 2.71

The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction. Pharmacoepidemiol Drug Saf (2012) 2.70

Identification of individuals with CKD from Medicare claims data: a validation study. Am J Kidney Dis (2005) 2.65

The increasing prevalence of atrial fibrillation among hemodialysis patients. J Am Soc Nephrol (2011) 2.61

Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies. Eur J Cancer (2011) 2.59

Age-related changes of nuclear architecture in Caenorhabditis elegans. Proc Natl Acad Sci U S A (2005) 2.57

Performance of propensity score calibration--a simulation study. Am J Epidemiol (2007) 2.56

Adjusting effect estimates for unmeasured confounding with validation data using propensity score calibration. Am J Epidemiol (2005) 2.55

Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J (2007) 2.55

Molecular characterization of the role of orphan receptor small heterodimer partner in development of fatty liver. Hepatology (2007) 2.53

Challenges in the development of high protein concentration formulations. J Pharm Sci (2004) 2.52

Medicaid prior-authorization programs and the use of cyclooxygenase-2 inhibitors. N Engl J Med (2004) 2.52

Primary fascial closure with mesh reinforcement is superior to bridged mesh repair for abdominal wall reconstruction. J Am Coll Surg (2013) 2.42

Evaluating uses of data mining techniques in propensity score estimation: a simulation study. Pharmacoepidemiol Drug Saf (2008) 2.42

A genome-wide siRNA screen reveals multiple mTORC1 independent signaling pathways regulating autophagy under normal nutritional conditions. Dev Cell (2010) 2.40

Dementia subtypes in China: prevalence in Beijing, Xian, Shanghai, and Chengdu. Arch Neurol (2005) 2.39

NF-kappaB p65-dependent transactivation of miRNA genes following Cryptosporidium parvum infection stimulates epithelial cell immune responses. PLoS Pathog (2009) 2.32

Loss of human epidermal growth factor receptor 2 (HER2) expression in metastatic sites of HER2-overexpressing primary breast tumors. J Clin Oncol (2011) 2.29

Four plasmepsins are active in the Plasmodium falciparum food vacuole, including a protease with an active-site histidine. Proc Natl Acad Sci U S A (2002) 2.24

Preference-based instrumental variable methods for the estimation of treatment effects: assessing validity and interpreting results. Int J Biostat (2007) 2.24

Mechanism of SMRT corepressor recruitment by the BCL6 BTB domain. Mol Cell (2003) 2.20

Treatment of older adult patients diagnosed with rheumatoid arthritis: improved but not optimal. Arthritis Rheum (2007) 2.18

Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis. Proc Natl Acad Sci U S A (2010) 2.16

Preoperative A1C and clinical outcomes in patients with diabetes undergoing major noncardiac surgical procedures. Diabetes Care (2013) 2.14

Effect of c-erbB2 overexpression on prognosis in osteosarcoma: evidence from eight studies. Tumour Biol (2014) 2.14

Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implications. Am J Med (2012) 2.13

Reduced incidence of breast cancer-related lymphedema following mastectomy and breast reconstruction versus mastectomy alone. Plast Reconstr Surg (2012) 2.13

Assessing health state utilities in elderly patients at cardiovascular risk. Med Decis Making (2006) 2.12

HIV-specific IL-21 producing CD4+ T cells are induced in acute and chronic progressive HIV infection and are associated with relative viral control. J Immunol (2010) 2.10

Trouble getting started: predictors of primary medication nonadherence. Am J Med (2011) 2.09

Lipofilling of the Breast Does Not Increase the Risk of Recurrence of Breast Cancer: A Matched Controlled Study. Plast Reconstr Surg (2016) 2.05

Evidence for pore formation in host cell membranes by ESX-1-secreted ESAT-6 and its role in Mycobacterium marinum escape from the vacuole. Infect Immun (2008) 2.05

Polymorphic variation of CYP11B2 predicts postoperative resolution of hypertension in patients undergoing adrenalectomy for aldosterone-producing adenomas. Int J Urol (2012) 2.04

Patterns of second-line uterotonic use in a large sample of hospitalizations for childbirth in the United States: 2007-2011. Anesth Analg (2014) 2.04

Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome. Ann Surg (2009) 2.04

Cortical thinning in persons at increased familial risk for major depression. Proc Natl Acad Sci U S A (2009) 2.04

Association between the Part D coverage gap and adverse health outcomes. J Am Geriatr Soc (2012) 1.99

Lamin-dependent localization of UNC-84, a protein required for nuclear migration in Caenorhabditis elegans. Mol Biol Cell (2002) 1.98

GRACE principles: recognizing high-quality observational studies of comparative effectiveness. Am J Manag Care (2010) 1.98

Association between Agent Orange exposure and nonmelanotic invasive skin cancer: a pilot study. Plast Reconstr Surg (2014) 1.97

Mmp-9 deficiency enhances collagenase-induced intracerebral hemorrhage and brain injury in mutant mice. J Cereb Blood Flow Metab (2004) 1.97

Descending command systems for the initiation of locomotion in mammals. Brain Res Rev (2007) 1.97

Systematic genetic nomenclature for type VII secretion systems. PLoS Pathog (2009) 1.96

Instrumental variable methods in comparative safety and effectiveness research. Pharmacoepidemiol Drug Saf (2010) 1.96

Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis. Arthritis Rheum (2006) 1.95

European healthcare policies for controlling drug expenditure. Pharmacoeconomics (2003) 1.95

Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk. Arthritis Rheum (2006) 1.94

Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States. Am J Kidney Dis (2011) 1.92

Identification of serum-derived sphingosine-1-phosphate as a small molecule regulator of YAP. Chem Biol (2012) 1.91

Signal transduction during cold, salt, and drought stresses in plants. Mol Biol Rep (2011) 1.89

The orphan nuclear receptor SHP regulates PGC-1alpha expression and energy production in brown adipocytes. Cell Metab (2005) 1.89

Targeted disruption of G0/G1 switch gene 2 enhances adipose lipolysis, alters hepatic energy balance, and alleviates high-fat diet-induced liver steatosis. Diabetes (2013) 1.87

A regulatory toolbox of MiniPromoters to drive selective expression in the brain. Proc Natl Acad Sci U S A (2010) 1.85